These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24090935)

  • 1. Preface: the liver in systemic disease.
    Neuberger J
    Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):469. PubMed ID: 24090935
    [No Abstract]   [Full Text] [Related]  

  • 2. Preface. Hepatobiliary manifestations of systemic diseases.
    Hu KQ
    Clin Liver Dis; 2011 Feb; 15(1):xiii-xiv. PubMed ID: 21111989
    [No Abstract]   [Full Text] [Related]  

  • 3. Preface - Animal models in liver disease.
    Fickert P; Wagner M
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):867-868. PubMed ID: 30826179
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraoperative systemic and hepatic hemodynamics associated with fulminant hepatic failure: comparison with chronic end-stage liver disease.
    Gunning TC; Paulsen AW; Brajtbord D; Goldstein RM; Ramsay MA
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1569. PubMed ID: 1989294
    [No Abstract]   [Full Text] [Related]  

  • 5. The involvement of the liver in systemic diseases.
    Malnick S; Melzer E; Sokolowski N; Basevitz A
    J Clin Gastroenterol; 2008 Jan; 42(1):69-80. PubMed ID: 18097294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Features of functional myocardial disorders, intracardiac and systemic hemodynamics in chronic diffuse liver diseases].
    Vasil'ev AIu; Zharikova MV; Penkina TV; Postnova NA
    Voen Med Zh; 2003 Nov; 324(11):33-5. PubMed ID: 14725076
    [No Abstract]   [Full Text] [Related]  

  • 7. Need of stratifying patients according to severity of underlying liver disease for hepatocellular carcinoma patients undergoing systemic therapy trials.
    Yeo W; Mo FK; Hui P; Chan SL
    Contemp Clin Trials; 2010 Mar; 31(2):135. PubMed ID: 20123038
    [No Abstract]   [Full Text] [Related]  

  • 8. Collagenoses and cutaneous manifestations of hepar diseases.
    Pietrzak A; Czelej D; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):415-8. PubMed ID: 12898872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific changes in hematopoiesis in chronic liver diseases].
    Strohmeyer G; Kuni H
    Verh Dtsch Ges Inn Med; 1968; 74():622-3. PubMed ID: 5714398
    [No Abstract]   [Full Text] [Related]  

  • 10. Interrelationship between type of spontaneous portal systemic shunt and portal vein pressure in patients with liver disease.
    Ohnishi K; Nakayama T; Koen H; Saito M; Saito M; Chin N; Terabayashi H; Iida S; Nomura F; Okuda K
    Am J Gastroenterol; 1985 Jul; 80(7):561-4. PubMed ID: 4014107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrition and liver disease: complex connections.
    Hasse JM
    Nutr Clin Pract; 2013 Feb; 28(1):12-4. PubMed ID: 23319352
    [No Abstract]   [Full Text] [Related]  

  • 12. Autonomic neuropathy in advanced liver disease.
    Trevisani F; Sica G; Bernardi M
    Hepatology; 1996 Dec; 24(6):1549. PubMed ID: 8938197
    [No Abstract]   [Full Text] [Related]  

  • 13. Polycystic disease of the liver.
    Burkitt R
    Proc R Soc Med; 1969 Aug; 62(8):820. PubMed ID: 5810296
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipocytes--their importance in physiology and pathology of the liver].
    Miszewska-Szyszkowska D; Paczek L
    Pol Arch Med Wewn; 1999 Apr; 101(4):345-51. PubMed ID: 10740414
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxygen: modulator of metabolic zonation and disease of the liver.
    Jungermann K; Kietzmann T
    Hepatology; 2000 Feb; 31(2):255-60. PubMed ID: 10655244
    [No Abstract]   [Full Text] [Related]  

  • 16. [On determination of liver circulation with colloidal Au-198 in chronic liver diseases].
    Szántay I; Cotul S; Tamás S; Vaida T
    Rev Roum Med Intern; 1972; 9(2):135-40. PubMed ID: 4561305
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thyroid function in liver disease (author's transl)].
    Imler M; Schlienger JL
    Gastroenterol Clin Biol; 1981 Mar; 5(3):332-9. PubMed ID: 7014345
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renal dysfunction in liver diseases].
    Rychalska-Glanc B
    Przegl Epidemiol; 1975; 29(2):229-33. PubMed ID: 1096246
    [No Abstract]   [Full Text] [Related]  

  • 19. Apoptosis in liver disease.
    Neuman MG
    Rom J Gastroenterol; 2002 Mar; 11(1):3-7. PubMed ID: 12096306
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physical activity in liver diseases and liver function in athletes].
    Ritland S; Foss NE; Gjone E
    Tidsskr Nor Laegeforen; 1980 May; 100(12B):847-51. PubMed ID: 7404532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.